Patent · US Expired

CD4-independent HIV envelope proteins as vaccines and therapeutics

US6849261B2 · kind B2 · utility

1Cited by
4References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 16, 2002
Grant dateFeb 1, 2005
Priority date
Expiry dateJul 16, 2022

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/16122
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention relates to novel CD4-independent HIV Envelope proteins and uses therefor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.